» Articles » PMID: 23223843

[Dexmedetomidine. Pharmacokinetics and Pharmacodynamics]

Overview
Journal Anaesthesist
Specialty Anesthesiology
Date 2012 Dec 11
PMID 23223843
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Dexmedetomidine is a highly selective, potent α₂-adrenoceptor agonist which was approved in 2011 by the European Medicines Agency for sedation of patients in intensive care units (ICU). Dexmedetomidine exhibits sedative as well as analgesic and anxiolytic effects. Recent studies suggest that dexmedetomidine may be an alternative to midazolam in long-term ICU sedation. This review summarizes the pharmacokinetics and pharmacodynamics of dexmedetomidine particularly in ICU patients and with special regard to covariate effects. Although dexmedetomidine is currently approved only for use in adults the pharmacokinetics and pharmacodynamics in children will also be addressed as there are numerous studies on this off-label use.

Citing Articles

Nalmefene vs. dexmedetomidine for prevention of postoperative hyperalgesia in patients undergoing laparoscopic gynecological surgery with remifentanil infusion: A randomized double-blind controlled trial.

Jia Z, Chen Y, Gao T, Yuan Y, Zheng Y, Xie Y Front Pharmacol. 2023; 14:1131812.

PMID: 36762101 PMC: 9905252. DOI: 10.3389/fphar.2023.1131812.


Recent Advances in the Clinical Value and Potential of Dexmedetomidine.

Liu X, Li Y, Kang L, Wang Q J Inflamm Res. 2022; 14:7507-7527.

PMID: 35002284 PMC: 8724687. DOI: 10.2147/JIR.S346089.


Effect of dexmedetomidine on hemodynamic changes and inflammatory responses in patients undergoing off-pump coronary-artery bypass grafting.

Zhai W, Yang L, Sun P, Li Y, Han J, Wang G Exp Ther Med. 2020; 20(6):250.

PMID: 33178348 PMC: 7651881. DOI: 10.3892/etm.2020.9380.


Comparison of midazolam and low-dose dexmedetomidine in flexible bronchoscopy: A prospective, randomized, double-blinded study.

Magazine R, Venkatachala S, Goneppanavar U, Surendra V, Guddattu V, Chogtu B Indian J Pharmacol. 2020; 52(1):23-30.

PMID: 32201443 PMC: 7074428. DOI: 10.4103/ijp.IJP_287_19.


Dexmedetomidine-based monitored conscious sedation combined local anesthesia for levator resection in a 10-year-old child with Marcus Gunn jaw-winking synkinesis: A case report.

Tu Y, Gao F Medicine (Baltimore). 2018; 96(51):e9369.

PMID: 29390531 PMC: 5758233. DOI: 10.1097/MD.0000000000009369.


References
1.
Talke P, Richardson C, Scheinin M, Fisher D . Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg. 1997; 85(5):1136-42. DOI: 10.1097/00000539-199711000-00033. View

2.
Albrecht S, Ihmsen H, Hering W, Geisslinger G, Dingemanse J, Schwilden H . The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther. 1999; 65(6):630-9. DOI: 10.1016/S0009-9236(99)90084-X. View

3.
Devlin J, Mallow-Corbett S, Riker R . Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med. 2010; 38(6 Suppl):S231-43. DOI: 10.1097/CCM.0b013e3181de125a. View

4.
Venn R, Hell J, Grounds R . Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000; 4(5):302-8. PMC: 29047. DOI: 10.1186/cc712. View

5.
Diedrich D, Brown D . Analytic reviews: propofol infusion syndrome in the ICU. J Intensive Care Med. 2011; 26(2):59-72. DOI: 10.1177/0885066610384195. View